Q32 Bio Inc.
QTTB
$1.70
$0.0150.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.19M | -17.60M | -16.98M | 1.03M | -27.07M |
| Total Depreciation and Amortization | 120.00K | 123.00K | 121.00K | 123.00K | 124.00K |
| Total Amortization of Deferred Charges | 49.00K | 50.00K | 66.00K | 29.00K | 30.00K |
| Total Other Non-Cash Items | 1.62M | 1.18M | 1.33M | -15.16M | 1.86M |
| Change in Net Operating Assets | 974.00K | -3.28M | -6.76M | -576.00K | 14.34M |
| Cash from Operations | -11.43M | -19.52M | -22.21M | -14.55M | -10.72M |
| Capital Expenditure | -2.00K | -58.00K | -15.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 10.00M | 9.90M | 97.00K | -- |
| Cash from Investing | -2.00K | 9.94M | 9.89M | 97.00K | 0.00 |
| Total Debt Issued | -53.16M | 0.00 | 0.00 | 60.16M | 0.00 |
| Total Debt Repaid | 8.71M | 0.00 | -5.90M | -2.81M | 0.00 |
| Issuance of Common Stock | 317.00K | 997.00K | 380.00K | 42.00M | 76.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.44M | -- | -- | -- | -- |
| Cash from Financing | 317.00K | 997.00K | -5.52M | 99.35M | 76.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.11M | -8.58M | -17.85M | 84.89M | -10.64M |